We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Pharsight and FDA Collaborate on Critical Path Initiative

News   Jun 13, 2006

 
Pharsight and FDA Collaborate on Critical Path Initiative
 
 
 

RELATED ARTICLES

Early Benefit Assessment Exposes Weaknesses in the Development of New Drugs

News

More than half of the drugs that have entered the market in Germany since then have emerged from these assessments without any proven added benefit. In a new publication using the first 216 assessments, researchers examine the reasons for this sobering result and develop suggestions for improvements in drug development.

READ MORE

Clinical Trial for New Anti-obesity Drug Set to Launch

News

The Alberta Diabetes Institute will be at the centre of a new clinical trial for an anti-obesity drug targeting people with rare genetic conditions that contribute to their obesity.

READ MORE

Team Develop Nanoscale Bioabsorbable Wound Dressing

News

Scientists are harnessing the combined power of organic nanomaterials-based chemistry and a natural product found in crustacean exoskeletons to help bring emergency medicine one step closer to a viable solution for mitigating blood loss, from the hospital to the battlefield.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE